News

Find News

Filter articles

Applied Filters

Showing 131 to 140 of 1033 results

Ruling opens door for Noven’s oestrogen patch generics

US10-09-2020Sarah Morgan

In a victory for pharmaceutical company Amneal, a Delaware court has invalidated claims of three patents covering Noven Pharmaceuticals’ Minivelle oestrogen product.

Amarin vows to challenge Vascepa patent ruling

International, US04-09-2020Muireann Bolger

Amarin has announced it will seek an en banc rehearing of a decision at the US Court of Appeals for the Federal Circuit that failed to revive its patents on heart medicine Vascepa.

Sigmapharm to appeal Pfizer and BMS’ Eliquis win

03-09-2020Rory O'Neill

Generics maker Sigmapharm Laboratories is appealing against a court win for Pfizer and Bristol Myers Squibb over patents for blood-thinner Eliquis.

Gilead signs deal to license new cancer treatment

International02-09-2020Muireann Bolger

Gilead Sciences has unveiled an agreement with Jounce Therapeutics to exclusively develop and license its antibody programme, JTX-1811, which is designed to fight cancer cells.

Teva charged in DoJ antitrust probe into generic drug price-fixing

US26-08-2020Legal developmentsMuireann Bolger

Teva Pharmaceuticals has been charged with conspiring to fix prices, rig bids, and allocate customers for generic drugs, the US Department of Justice has announced.

Intercept sues Apotex over Ocaliva generic

26-08-2020Rory O'Neill

Intercept Pharmaceuticals is suing Canadian generics manufacturer Apotex over a proposed version of autoimmune drug Ocaliva.

Judge allows Dr Reddy’s to add antitrust claims in Indivior dispute

US25-08-2020Sarah Morgan

A district judge has given India-based Dr Reddy’s the greenlight to move forward with its antitrust counterclaims against Indivior. 

Mylan launches Tecfidera generic amid Biogen battle

US20-08-2020Sarah Morgan

Mylan launched its generic version of Biogen’s $4 billion-a-year multiple sclerosis drug Tecfidera yesterday, August 19.

FDA approves Dr Reddy’s Vascepa generic

US13-08-2020Rory O'Neill

Indian drugmaker Dr Reddy’s has won approval to launch just the second generic version of heart drug Vascepa, in another blow for Amarin.

Teva sues Cipla over generic asthma inhalers

11-08-2020Rory O'Neill

Israeli drug manufacturer Teva Pharmaceuticals is suing India-based Cipla to block the launch of generic Qvar asthma inhalers.

Showing 131 to 140 of 1033 results

LSIPR